Bharat biotech in collaboration with ICMR ( Indian council of medical research ) developed Covid-19 vaccine called COVAXIN . Over seven vaccines are being researched in India and only COVAXIN and Zydus cadilla got the approval to start human trials . ICMR is looking to launch COVAXIN by August 15 on India’s independence day . After getting green signal from all the concerned authorities .
” Strict fast tracking of all approvals related to initiation of clinical trials and ensuring that the subject enrollment is initiated no later than July 7 2020 ” instructed by Balram Bhargava , ICMR council director in letter. ” This is the first indigenous vaccine being developed by India and is one of the top priority projects, which is being monitor at the top highest level of government . The vaccine is derived from a strain of SARS – Cov -2 isolated by ICMR – NIV ( National institute of virology ) ,Pune. The ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine “. Further noted in that letter by Balram Bhargava. ” Vaccine is top priority project which was being monitored at highest level of the government and non compliance will be viewed strictly ” he added .
Meanwhile, health experts are sceptical about this. A senior doctor of research in institute said ” if the date is August 15 2021, then it is workable . Recruiting patients has not started . We will follow the due process and are talking of human trials . It is serious business . He also mentioned “I am really surprised as the letter had come from ‘ Man of science ‘.
